Contributions of RegainRomilly

Contributions by RegainRomilly, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 1,611 edits includes activity predating the current log.

1. 23:29, 8 Jun 2026 (diff | hist) Aspiration risk under anaesthesia 4,681 ±0 expand §The mechanism and its magnitude
2. 02:42, 22 Mar 2026 (diff | hist) GenScript Peptides 17,613 +488 correct the regional-warehouse list — six sites, not five
3. 10:18, 28 Feb 2026 (diff | hist) Liquid chromatography-mass spectrometry 4,463 ±0 add the counterion determination method by name
4. 09:50, 30 Jan 2026 (diff | hist) Talk:Weight regain after discontinuation 400 +150 /* Lifelong treatment claim */ new section
5. 18:53, 3 Nov 2025 (diff | hist) Adverse effects of GLP-1 receptor agonists 5,791 ±0 rm the comparison with a compound that has no comparable safety dataset
6. 03:36, 23 Jul 2025 (diff | hist) Weight regain after discontinuation 4,624 ±0 clarify that dose-dependence is reported for some effects and not others
7. 01:19, 19 Jul 2025 (diff | hist) Adverse effects of GLP-1 receptor agonists 5,791 ±0 add the citation for the gallbladder finding
8. 03:06, 17 Jul 2025 (diff | hist) Bacteriostatic water 4,652 +111 add the shelf life after first puncture, attributed
9. 02:02, 1 Jun 2025 (diff | hist) Solid-phase peptide synthesis 5,359 +252 convert the storage conditions to a table
10. 13:48, 3 May 2025 (diff | hist) Haemoglobin A1c 3,396 +30 m clarify that the marker is method-dependent and not comparable across platforms
11. 09:17, 5 Jan 2025 (diff | hist) Blind sampling 4,821 +892 add the cost basis, since it shapes who submits
12. 10:23, 5 Sep 2024 (diff | hist) Adverse effects of GLP-1 receptor agonists 3,137 +523 rm the causal wording — spontaneous reports do not establish causation
13. 03:47, 10 Aug 2024 (diff | hist) Hypoglycaemia 1,779 +546 m add the monitoring recommendation as attributed to the labelling